US FDA approves Vertex's non-opioid painkiller
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
Future Market Insights2d
Global Antacids Market Poised for Significant Growth, Reaching USD 11,194.8 million by 2033 at a CAGR of 4.9%
The global antacids market is on track for substantial expansion, with projections indicating a rise from USD 6,971.2 million ...